Amendment117th Congress
An amendment numbered 36 printed in Part B of House Report 117-109 to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.
- Amendment Number
- 85
- Description
- An amendment numbered 36 printed in Part B of House Report 117-109 to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.
- Purpose
- Amendment sought to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.
- Congress
- 117
- Type
- HAMDT
- Latest Action Date
- Jul 27, 2021
- Latest Action Text
- On agreeing to the Ocasio-Cortez amendment (A007) Failed by the Yeas and Nays: 140 - 285 (Roll no. 230).
- Latest Action Time
- 22:13:53
- Submitted Date
- Jul 27, 2021
- Chamber
- House of Representatives
- Update Date
- Feb 9, 2022